Five years after the world was hit by the Covid-19 pandemic, China is now dealing with a new health challenge. The country is experiencing a rise in cases of the human metapneumovirus (HMPV), a respiratory illness that is spreading quickly. Reports on social media claim that hospitals and crematories are overwhelmed, raising concerns about the situation. Videos shared online show overcrowded hospitals, with some people saying that other viruses, like influenza A, Mycoplasma pneumoniae, and COVID-19, are also spreading at the same time.
Despite these alarming reports, neither the Chinese government nor the World Health Organization (WHO) has issued an official warning or declared an emergency. However, the increase in respiratory illnesses, especially among children and the elderly, has caught the attention of health experts and the public.
The surge in HMPV cases is particularly affecting young children and older adults. Children with developing immune systems are at a higher risk, while elderly people with pre-existing health conditions like asthma or chronic obstructive pulmonary disease (COPD) are more likely to experience severe complications.
The symptoms of HMPV are similar to those of a cold or the flu. People infected with the virus may experience fever, cough, and a runny nose. In severe cases, symptoms can worsen, leading to bronchitis or pneumonia. Some patients may even have difficulty breathing, requiring medical attention.
Health experts believe the recent rise in respiratory illnesses is linked to colder weather and the return to normal activities after years of strict COVID-19 lockdowns. During the pandemic, reduced social interaction helped limit the spread of many viruses. Now, as people resume normal life, many are encountering these viruses for the first time, leading to what experts call a “catch-up” period.
The situation is further complicated by the presence of multiple viruses circulating at the same time. This has added pressure on hospitals, especially those in northern provinces where the HMPV outbreak seems to be more severe.
ALSO READ: Machine Learning Has The Potential To Predict Pare Diseases
China’s health authorities are trying to address the issue by improving their monitoring systems. The National Disease Control and Prevention Administration (NCDPA) has launched a pilot system to track cases of pneumonia of unknown origin. This system is designed to help authorities quickly respond to outbreaks of respiratory diseases, especially during the winter months. This approach is a significant step forward compared to the initial days of the COVID-19 pandemic when the country struggled with unpreparedness.
Officials have also introduced new protocols requiring laboratories to report cases of respiratory illnesses. Disease control agencies will verify and handle these cases to ensure a quicker response. According to recent data, respiratory infections have been on the rise, with a noticeable increase reported during the week of December 16 to 22.
Kan Biao, an official with the NCDPA, has warned that respiratory diseases are likely to increase during the winter and spring seasons. However, he noted that the total number of cases this year is expected to be lower compared to last year. Despite this reassurance, the rising trend of respiratory infections among children, particularly those under 14, is a cause for concern. In addition to HMPV, cases of rhinovirus and other respiratory pathogens are also increasing.
ALSO READ: Korean Scientists Discover Reversible Cancer Treatment, Transform Tumor Cells to Normal
Medical professionals are urging people to take precautions. In an interview with the state-backed National Business Daily, a respiratory expert advised against the misuse of antiviral drugs. The expert explained that there is no specific vaccine or antiviral treatment for HMPV. Instead, the focus should be on managing symptoms and seeking medical attention in severe cases.
What is Human Metapneumovirus (HMPV)?
HMPV is a viral infection that usually causes symptoms similar to a common cold. These include a cough, fever, and a runny or blocked nose. While most infections are mild, the virus can sometimes lead to severe conditions such as pneumonia or asthma flare-ups.
The virus spreads through direct contact with infected individuals or contaminated surfaces. It is most commonly seen during the winter and early spring months. Children are especially vulnerable, with most contracting the virus before the age of five. Although people can get infected with HMPV more than once, repeat infections are usually less severe.
How Is HMPV Treated?
Currently, there are no specific treatments for HMPV. Most people recover on their own by managing symptoms at home. Rest, hydration, and over-the-counter medications can help alleviate mild symptoms. However, severe cases may require hospitalization. Doctors may use oxygen therapy to assist with breathing or intravenous fluids to prevent dehydration. In some cases, corticosteroids are administered to reduce inflammation.
Social media platforms are flooded with posts about the current health crisis in China. A popular account on X (formerly Twitter) shared alarming claims, stating that multiple viruses, including HMPV and COVID-19, are spreading rapidly, overwhelming hospitals and crematories. The post also highlighted the strain on children’s hospitals, particularly those dealing with rising pneumonia cases.
Videos and images showing crowded hospital wards and long lines outside crematories have added to the public’s concern. While some social media users have even claimed that China has declared a state of emergency, these reports remain unverified.